Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02635282 · ClinicalTrials.gov registry record · Phase 4
IN Ketamine Vs IN Midazolam and Fentanyl for Abscess I&D
A Phase 4 study, sponsored by University of Tennessee.
- Completed
- Registry status
- Phase 4
- Development phase
- 19
- Enrollment target
NCT02635282 is a Phase 4 study that has completed, run by University of Tennessee. The registered enrollment target is 19 participants.
The verdict
NCT02635282, a Phase 4 study, has completed, sponsored by University of Tennessee.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 19 participants
- Enrollment target
Study Summary
The general objective of this study is to determine whether intranasal ketamine should be incorporated into formulary as an option to treat pain during minor procedures in the pediatric emergency department.
Interventions
- DRUG intranasal ketamine
- DRUG intranasal fentanyl
- DRUG intranasal midazolam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2016-08 |
| Est. Completion | 2017-03-23 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02635282
The ClinicalTrials.gov registry entry for NCT02635282 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Tennessee, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which intranasal ketamine is the first listed.
NCT02635282 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02635282 about?
NCT02635282 is a clinical study titled "IN Ketamine Vs IN Midazolam and Fentanyl for Abscess I&D". The general objective of this study is to determine whether intranasal ketamine should be incorporated into formulary as an option to treat pain during minor procedures in the pediatric emergency department.
What is the current status of trial NCT02635282?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 19 participants. The study started on 2016-08. Estimated completion is 2017-03-23.
What interventions are being tested in trial NCT02635282?
The interventions under investigation include: intranasal ketamine (DRUG), intranasal fentanyl (DRUG), intranasal midazolam (DRUG).
Who is sponsoring clinical trial NCT02635282?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.